The Carlat Child Psychiatry Report

Psychosis in Children and Adolescent (April/May/June) | 2025

View Archived Issues

Learning Objectives, Psychosis in Children and Adolescents, CCPR, April/May/June 2025

April 1, 2025

After reading these articles, you should be able to… 

Read More

Note from the Editor In Chief, CCPR, April/May/June 2025

April 1, 2025
Joshua Feder, MD

Welcome back to CCPR! We interview Dr. Kristin Cadenhead on psychotic-like experiences, Dr. David Beckman on substance-related psychosis, and Julie Dopheide, PharmD, on metabolic-sparing antipsychotics. We also cover selective mutism, cardiovascular effects of ADHD medications, and a caution from Danielle Reynolds, MS IV, on Delta-8 – warn your patients!

Read More

Selective Mutism: Helping Kids Find Their Voice

April 1, 2025
Mariel Zeccola, APRN, PhD

Selective mutism (SM) in children can create tremendous frustration, often resulting in harsh reactions from parents or teachers. This clinical update from our own Dr. Mariel Zeccola will help you differentiate SM from co-occurring anxiety and other conditions and offer a path to treatment with therapy and, when needed, medication. 

Read More

Sorting Out Psychotic-Like Experiences in Children and Teens

April 1, 2025
Kristin Cadenhead, MD

What are psychotic-like experiences (PLE) in children and teens, and what is the prognosis for those who have them? Should we treat immediately with antipsychotics? Watch and wait? Our interview with Dr. Kristin Cadenhead gives you the guidance you need to assess and manage PLE.

Read More

Managing Substance-Induced Psychosis in Teens

April 1, 2025
David Beckmann, MD, MPH

How do we decide whether a psychotic condition is due to substance use or a primary condition, and how does that affect our care of the patient? We spoke with Dr. David Beckmann about substance-induced psychosis in teens to help us outline the workup and approach to this common clinical conundrum. 

Read More

Antipsychotics and Weight Gain in Younger Patients

April 1, 2025
Julie Ann Dopheide, PharmD, BCPP, FASHP

Julie Ann Dopheide, PharmD, BCPP, FASHP, Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and Keck School of Medicine, University of Southern California, Los Angeles, CA.
Dr. Dopheide has no financial relationships with companies related to this material.

Read More

Long-Term Cardiovascular Risks of ADHD Medications: A Closer Look

April 1, 2025
Joshua Feder, MD

We know that stimulant medications for ADHD can reduce chronic health conditions and extend healthy years for patients. But are there cardiovascular risks from these or non-stimulant medications used for ADHD? In this research update, we review a study that helps clarify the risks of long term use in youth and adults. 

Read More

CME Post-Test, Psychosis in Children and Adolescents, CCPR, April/May/June 2025

April 1, 2025

By successfully completing the test you will be awarded a certificate for 1 CME credit.

Read More
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.